Click here to get full coverage on Azenta Authorizes $250 Million Share Repurchase Program - PR Newswire

Azenta Authorizes $250 Million Share Repurchase Program  PR Newswire

Azenta Authorizes $250 Million Share Repurchase Program - PR Newswire

Click here to get full coverage on How Investors May Respond To Azenta (AZTA) Cash Strength Paired With Internal Control Weakness - Yahoo Finance

How Investors May Respond To Azenta (AZTA) Cash Strength Paired With Internal Control Weakness  Yahoo Finance

How Investors May Respond To Azenta (AZTA) Cash Strength Paired With Internal Control Weakness - Yahoo Finance

Click here to get full coverage on Is Azenta’s US$250 Million Buyback And M&A Push Altering The Investment Case For AZTA? - simplywall.st

Is Azenta’s US$250 Million Buyback And M&A Push Altering The Investment Case For AZTA?  simplywall.st

Is Azenta’s US$250 Million Buyback And M&A Push Altering The Investment Case For AZTA? - simplywall.st

Click here to get full coverage on Natixis Takes Position in Azenta, Inc. $AZTA - MarketBeat

Natixis Takes Position in Azenta, Inc. $AZTA  MarketBeat

Natixis Takes Position in Azenta, Inc. $AZTA - MarketBeat

Click here to get full coverage on Jefferies Upgrades Azenta(AZTA.US) to Buy Rating, Cuts Target Price to $42 - 富途牛牛

Jefferies Upgrades Azenta(AZTA.US) to Buy Rating, Cuts Target Price to $42  富途牛牛

Jefferies Upgrades Azenta(AZTA.US) to Buy Rating, Cuts Target Price to $42 - 富途牛牛

Click here to get full coverage on $AZTA stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

$AZTA stock is up 15% today. Here's what we see in our data.  Quiver Quantitative

$AZTA stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Why Azenta (AZTA) Stock Is Up Today - MSN

Why Azenta (AZTA) Stock Is Up Today  MSN

Why Azenta (AZTA) Stock Is Up Today - MSN

Click here to get full coverage on Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings - Finviz

Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings  Finviz

Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings - Finviz

Click here to get full coverage on Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 - PR Newswire

Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025  PR Newswire

Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 - PR Newswire

Click here to get full coverage on Why Azenta (AZTA) Stock Is Trading Up Today - Yahoo Finance

Why Azenta (AZTA) Stock Is Trading Up Today  Yahoo Finance

Why Azenta (AZTA) Stock Is Trading Up Today - Yahoo Finance

Click here to get full coverage on Stock Repurchase Program Declared by Azenta (NASDAQ:AZTA) - MarketBeat

Stock Repurchase Program Declared by Azenta (NASDAQ:AZTA)  MarketBeat

Stock Repurchase Program Declared by Azenta (NASDAQ:AZTA) - MarketBeat

Click here to get full coverage on AZENTA Earnings Preview: Recent $AZTA Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

AZENTA Earnings Preview: Recent $AZTA Insider Trading, Hedge Fund Activity, and More  Quiver Quantitative

AZENTA Earnings Preview: Recent $AZTA Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Click here to get full coverage on Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks - Yahoo Finance

Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks  Yahoo Finance

Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks - Yahoo Finance

Click here to get full coverage on Assessing Azenta (AZTA) Valuation After Meros’ New Stake and Margin Expansion Progress - simplywall.st

Assessing Azenta (AZTA) Valuation After Meros’ New Stake and Margin Expansion Progress  simplywall.st

Assessing Azenta (AZTA) Valuation After Meros’ New Stake and Margin Expansion Progress - simplywall.st

Click here to get full coverage on How Investors May Respond To Azenta (AZTA) Delaying Its 10-K Filing And Financial Disclosures - simplywall.st

How Investors May Respond To Azenta (AZTA) Delaying Its 10-K Filing And Financial Disclosures  simplywall.st

How Investors May Respond To Azenta (AZTA) Delaying Its 10-K Filing And Financial Disclosures - simplywall.st

Click here to get full coverage on New Analyst Forecast: $AZTA Given $42.0 Price Target - Quiver Quantitative

New Analyst Forecast: $AZTA Given $42.0 Price Target  Quiver Quantitative

New Analyst Forecast: $AZTA Given $42.0 Price Target - Quiver Quantitative

Click here to get full coverage on Raymond James Maintains Azenta (AZTA) Outperform Recommendation - Nasdaq

Raymond James Maintains Azenta (AZTA) Outperform Recommendation  Nasdaq

Raymond James Maintains Azenta (AZTA) Outperform Recommendation - Nasdaq

Click here to get full coverage on Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales - Finviz

Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales  Finviz

Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales - Finviz

Click here to get full coverage on Azenta (AZTA) Q4 Profit Surge Tests Bullish Margin-Rebuild Narrative - Sahm

Azenta (AZTA) Q4 Profit Surge Tests Bullish Margin-Rebuild Narrative  Sahm

Azenta (AZTA) Q4 Profit Surge Tests Bullish Margin-Rebuild Narrative - Sahm

Click here to get full coverage on Azenta: Life Science Player Coming To Life - Seeking Alpha

Azenta: Life Science Player Coming To Life  Seeking Alpha

Azenta: Life Science Player Coming To Life - Seeking Alpha

Click here to get full coverage on Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets - Yahoo Finance

Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets  Yahoo Finance

Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets - Yahoo Finance

Click here to get full coverage on AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion - Yahoo Finance

AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion  Yahoo Finance

AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion - Yahoo Finance

Click here to get full coverage on Why Azenta (AZTA) Stock Is Trading Lower Today - Yahoo Finance

Why Azenta (AZTA) Stock Is Trading Lower Today  Yahoo Finance

Why Azenta (AZTA) Stock Is Trading Lower Today - Yahoo Finance

Click here to get full coverage on Azenta, Inc. Authorizes $250 Million Share Repurchase Program - TradingView — Track All Markets

Azenta, Inc. Authorizes $250 Million Share Repurchase Program  TradingView — Track All Markets

Azenta, Inc. Authorizes $250 Million Share Repurchase Program - TradingView — Track All Markets

Click here to get full coverage on Is Azenta Stock Outperforming Its Rivals? - Trefis

Is Azenta Stock Outperforming Its Rivals?  Trefis

Is Azenta Stock Outperforming Its Rivals? - Trefis

Click here to get full coverage on Azenta (AZTA): Evaluating Valuation After 16% Share Price Jump Spurs Turnaround Talk - simplywall.st

Azenta (AZTA): Evaluating Valuation After 16% Share Price Jump Spurs Turnaround Talk  simplywall.st

Azenta (AZTA): Evaluating Valuation After 16% Share Price Jump Spurs Turnaround Talk - simplywall.st

Click here to get full coverage on Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana - PR Newswire

Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana  PR Newswire

Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana - PR Newswire

Click here to get full coverage on Decoding Azenta Inc (AZTA): A Strategic SWOT Insight - GuruFocus

Decoding Azenta Inc (AZTA): A Strategic SWOT Insight  GuruFocus

Decoding Azenta Inc (AZTA): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on Azenta, Inc. $AZTA Shares Sold by JPMorgan Chase & Co. - MarketBeat

Azenta, Inc. $AZTA Shares Sold by JPMorgan Chase & Co.  MarketBeat

Azenta, Inc. $AZTA Shares Sold by JPMorgan Chase & Co. - MarketBeat

Click here to get full coverage on Azenta, Inc. $AZTA Shares Sold by Schroder Investment Management Group - MarketBeat

Azenta, Inc. $AZTA Shares Sold by Schroder Investment Management Group  MarketBeat

Azenta, Inc. $AZTA Shares Sold by Schroder Investment Management Group - MarketBeat

Click here to get full coverage on Here’s What Pressured Azenta (AZTA) in Q2 - Yahoo Finance

Here’s What Pressured Azenta (AZTA) in Q2  Yahoo Finance

Here’s What Pressured Azenta (AZTA) in Q2 - Yahoo Finance

Click here to get full coverage on Azenta, Inc. (NASDAQ:AZTA) Q4 2025 Earnings Call Transcript - Insider Monkey

Azenta, Inc. (NASDAQ:AZTA) Q4 2025 Earnings Call Transcript  Insider Monkey

Azenta, Inc. (NASDAQ:AZTA) Q4 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Jefferies Upgrades Azenta (AZTA) - Nasdaq

Jefferies Upgrades Azenta (AZTA)  Nasdaq

Jefferies Upgrades Azenta (AZTA) - Nasdaq

Click here to get full coverage on Azenta's (NASDAQ:AZTA) Earnings Offer More Than Meets The Eye - simplywall.st

Azenta's (NASDAQ:AZTA) Earnings Offer More Than Meets The Eye  simplywall.st

Azenta's (NASDAQ:AZTA) Earnings Offer More Than Meets The Eye - simplywall.st

Click here to get full coverage on 9,202 Shares in Azenta, Inc. $AZTA Acquired by ProShare Advisors LLC - MarketBeat

9,202 Shares in Azenta, Inc. $AZTA Acquired by ProShare Advisors LLC  MarketBeat

9,202 Shares in Azenta, Inc. $AZTA Acquired by ProShare Advisors LLC - MarketBeat

Click here to get full coverage on Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)? - simplywall.st

Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)?  simplywall.st

Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)? - simplywall.st

Click here to get full coverage on 3 Healthcare Stocks We’re Skeptical Of - The Globe and Mail

3 Healthcare Stocks We’re Skeptical Of  The Globe and Mail

3 Healthcare Stocks We’re Skeptical Of - The Globe and Mail

Click here to get full coverage on Fisher Asset Management LLC Sells 81,724 Shares of Azenta, Inc. $AZTA - MarketBeat

Fisher Asset Management LLC Sells 81,724 Shares of Azenta, Inc. $AZTA  MarketBeat

Fisher Asset Management LLC Sells 81,724 Shares of Azenta, Inc. $AZTA - MarketBeat

Click here to get full coverage on 11,199 Shares in Azenta, Inc. $AZTA Purchased by Inceptionr LLC - MarketBeat

11,199 Shares in Azenta, Inc. $AZTA Purchased by Inceptionr LLC  MarketBeat

11,199 Shares in Azenta, Inc. $AZTA Purchased by Inceptionr LLC - MarketBeat

Click here to get full coverage on Why Azenta (AZTA) Stock Is Trading Up Today - The Globe and Mail

Why Azenta (AZTA) Stock Is Trading Up Today  The Globe and Mail

Why Azenta (AZTA) Stock Is Trading Up Today - The Globe and Mail

Click here to get full coverage on Capital Fund Management S.A. Boosts Stock Holdings in Azenta, Inc. $AZTA - MarketBeat

Capital Fund Management S.A. Boosts Stock Holdings in Azenta, Inc. $AZTA  MarketBeat

Capital Fund Management S.A. Boosts Stock Holdings in Azenta, Inc. $AZTA - MarketBeat

Click here to get full coverage on Azenta (AZTA) Surpasses Q4 Expectations with Strong Revenue Grow - GuruFocus

Azenta (AZTA) Surpasses Q4 Expectations with Strong Revenue Grow  GuruFocus

Azenta (AZTA) Surpasses Q4 Expectations with Strong Revenue Grow - GuruFocus

Click here to get full coverage on SG Americas Securities LLC Sells 23,232 Shares of Azenta, Inc. $AZTA - MarketBeat

SG Americas Securities LLC Sells 23,232 Shares of Azenta, Inc. $AZTA  MarketBeat

SG Americas Securities LLC Sells 23,232 Shares of Azenta, Inc. $AZTA - MarketBeat

Click here to get full coverage on Precision Trading with Azenta Inc. (AZTA) Risk Zones - news.stocktradersdaily.com

Precision Trading with Azenta Inc. (AZTA) Risk Zones  news.stocktradersdaily.com

Precision Trading with Azenta Inc. (AZTA) Risk Zones - news.stocktradersdaily.com

Click here to get full coverage on Strong week for Azenta (NASDAQ:AZTA) shareholders doesn't alleviate pain of five-year loss - simplywall.st

Strong week for Azenta (NASDAQ:AZTA) shareholders doesn't alleviate pain of five-year loss  simplywall.st

Strong week for Azenta (NASDAQ:AZTA) shareholders doesn't alleviate pain of five-year loss - simplywall.st

Click here to get full coverage on Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care - PR Newswire

Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care  PR Newswire

Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care - PR Newswire

Click here to get full coverage on AZTA - Azenta Inc Latest Stock News & Market Updates - Stock Titan

AZTA - Azenta Inc Latest Stock News & Market Updates  Stock Titan

AZTA - Azenta Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - PR Newswire

Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development  PR Newswire

Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - PR Newswire

Click here to get full coverage on Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales - The Globe and Mail

Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales  The Globe and Mail

Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales - The Globe and Mail

Click here to get full coverage on Azenta (AZTA) Projects Significant EBITDA Margin Growth by 2025 - GuruFocus

Azenta (AZTA) Projects Significant EBITDA Margin Growth by 2025  GuruFocus

Azenta (AZTA) Projects Significant EBITDA Margin Growth by 2025 - GuruFocus

Click here to get full coverage on Is Azenta's (AZTA) Role in Pancreatic Cancer Biorepository Shaping Its Medical Research Narrative? - Yahoo Finance

Is Azenta's (AZTA) Role in Pancreatic Cancer Biorepository Shaping Its Medical Research Narrative?  Yahoo Finance

Is Azenta's (AZTA) Role in Pancreatic Cancer Biorepository Shaping Its Medical Research Narrative? - Yahoo Finance

Click here to get full coverage on Azenta (AZTA) Stock Trades Up, Here Is Why - Yahoo Finance

Azenta (AZTA) Stock Trades Up, Here Is Why  Yahoo Finance

Azenta (AZTA) Stock Trades Up, Here Is Why - Yahoo Finance

Click here to get full coverage on Entropy Technologies LP Buys New Position in Azenta, Inc. $AZTA - MarketBeat

Entropy Technologies LP Buys New Position in Azenta, Inc. $AZTA  MarketBeat

Entropy Technologies LP Buys New Position in Azenta, Inc. $AZTA - MarketBeat

Click here to get full coverage on Why Azenta (AZTA) Stock Is Up Today - The Globe and Mail

Why Azenta (AZTA) Stock Is Up Today  The Globe and Mail

Why Azenta (AZTA) Stock Is Up Today - The Globe and Mail

Click here to get full coverage on Needham Maintains Azenta(AZTA.US) With Buy Rating, Maintains Target Price $42 - 富途牛牛

Needham Maintains Azenta(AZTA.US) With Buy Rating, Maintains Target Price $42  富途牛牛

Needham Maintains Azenta(AZTA.US) With Buy Rating, Maintains Target Price $42 - 富途牛牛

Click here to get full coverage on Azenta (AZTA) Surpasses Revenue Expectations for Q4 - GuruFocus

Azenta (AZTA) Surpasses Revenue Expectations for Q4  GuruFocus

Azenta (AZTA) Surpasses Revenue Expectations for Q4 - GuruFocus

Click here to get full coverage on Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings  The Globe and Mail

Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Click here to get full coverage on Azenta Announces $250 Million Share Repurchase Program - TipRanks

Azenta Announces $250 Million Share Repurchase Program  TipRanks

Azenta Announces $250 Million Share Repurchase Program - TipRanks

Click here to get full coverage on Azenta: Down 40% And Still Not Compelling (NASDAQ:AZTA) - Seeking Alpha

Azenta: Down 40% And Still Not Compelling (NASDAQ:AZTA)  Seeking Alpha

Azenta: Down 40% And Still Not Compelling (NASDAQ:AZTA) - Seeking Alpha

Click here to get full coverage on Azenta (Nasdaq: AZTA) sets earnings call for Q4 and full-year results on Nov. 21 - Stock Titan

Azenta (Nasdaq: AZTA) sets earnings call for Q4 and full-year results on Nov. 21  Stock Titan

Azenta (Nasdaq: AZTA) sets earnings call for Q4 and full-year results on Nov. 21 - Stock Titan

Click here to get full coverage on Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales - Barchart.com

Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales  Barchart.com

Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales - Barchart.com

Click here to get full coverage on Azenta Authorizes $250 Million Share Repurchase Program - WV News

Azenta Authorizes $250 Million Share Repurchase Program  WV News

Azenta Authorizes $250 Million Share Repurchase Program - WV News

Click here to get full coverage on Earnings Scheduled For November 21, 2025 - Benzinga

Earnings Scheduled For November 21, 2025  Benzinga

Earnings Scheduled For November 21, 2025 - Benzinga

Click here to get full coverage on Earnings Flash (AZTA) Azenta, Inc. Reports Q4 Revenue $159.2M, vs. FactSet Est of $156.2M - marketscreener.com

Earnings Flash (AZTA) Azenta, Inc. Reports Q4 Revenue $159.2M, vs. FactSet Est of $156.2M  marketscreener.com

Earnings Flash (AZTA) Azenta, Inc. Reports Q4 Revenue $159.2M, vs. FactSet Est of $156.2M - marketscreener.com

Click here to get full coverage on 3 Reasons to Avoid AZTA and 1 Stock to Buy Instead - Finviz

3 Reasons to Avoid AZTA and 1 Stock to Buy Instead  Finviz

3 Reasons to Avoid AZTA and 1 Stock to Buy Instead - Finviz

Click here to get full coverage on Azenta (NASDAQ:AZTA) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Azenta (NASDAQ:AZTA) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS  MarketBeat

Azenta (NASDAQ:AZTA) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Click here to get full coverage on Raymond James Maintains Azenta(AZTA.US) With Buy Rating, Raises Target Price to $45 - 富途牛牛

Raymond James Maintains Azenta(AZTA.US) With Buy Rating, Raises Target Price to $45  富途牛牛

AZTA

Price Chart

Key Statistics

Technicals

About AZTA

Latest News

Azenta Authorizes $250 Million Share Repurchase Program - PR Newswire

How Investors May Respond To Azenta (AZTA) Cash Strength Paired With Internal Control Weakness - Yahoo Finance

Is Azenta’s US$250 Million Buyback And M&A Push Altering The Investment Case For AZTA? - simplywall.st

Advanced Charts

Top Gainers

Top Losers